Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B
Clinical trial NCT00895596 · COMPLETED
Trial details
- NCT number
- NCT00895596
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2006-08-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.